| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |